Hyper-priming in cannabis users: A naturalistic study of the effects of cannabis on semantic memory function

Psychiatry Research

Volumn 176, Issue 2-3, 2010, Pages 213-218

  Morgan, Celia J A ^a   Rothwell, Emily ^a   Atkinson, Helen ^a   Mason, Oliver ^a   Curran, H Valerie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabis; Cognition; Drug abuse; Psychosis; Schizotypy; Semantic priming

Indexed keywords

ALCOHOL; CANNABIS;

ADULT; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; COGNITIVE DEFECT; CONTROLLED STUDY; DELUSION; DISEASE ASSOCIATION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; PARANOIA; PERCEPTION DISORDER; PRIORITY JOURNAL; PSYCHOSIS; REACTION TIME; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SEMANTIC MEMORY; SEMANTICS; TASK PERFORMANCE;

ADULT; ANALYSIS OF VARIANCE; CANNABINOIDS; CANNABIS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; SEMANTICS; TIME FACTORS; YOUNG ADULT;

EID: 77949772858     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.09.002     Document Type: Article

References (42)

1. Barkus E.J., Stirling J., Hopkins R.S., Lewis S. Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 2006, 39:175-178.
2. Battig W.F., Montague W.E. Category norms of verbal items in 56 categories. A replication and extension of the Connecticut category norms. Journal of Experimental Psychology 1969, 80:1-46.
3. Bleuler E. Dementia Praecox or the Group of Schizophrenias (translated by J.Zinkin, 1950), International Universities Press, New York. 1911.
4. Block R.I., Ghoneim M.M. Effects of chronic marijuana use on human cognition. Psychopharmacology (Berl) 1993, 110:219-228.
5. British Crime Survey (2006).Drug Misuse: one in three young men use cannabis http://www.statistics.gov.uk.
6. Curran H.V., Brignell C., Fletcher S., Middleton P., Henry J. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 2002, 164:61-70.
7. D'Souza D.C. Cannibinoids and psychosis. International reviews of neurobiology 2007, 78:289-326.
8. Dafters R.I., Hoshi R., Talbot A.C. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users. Psychopharmacology (Berl) 2004, 173:405-410.
9. Di Forti M., Morrison P.D., Butt A., Murray R.M. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?. Current Opinion in Psychiatry 2007, 20:228-234.
10. Ferdinand R.F., van der E.J., Bongers I., Selten J.P., Huizink A., Verhulst F.C. Cannabis-psychosis pathway independent of other types of psychopathology. Schizophrenia Research 2005, 79:289-295.
11. Fergusson D.M., Horwood L.J., Ridder E.M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005, 100:354-366.
12. Fletcher P.C., Honey G.D. Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits. Trends in Cognitive Sciences 2006, 10(4):167-174.
13. Forster K.I., Forster J.C. DMDX: a Windows display program with millisecond accuracy. Behavior Research Methods, Instruments & Computers 2003, 35:116-124.
14. Fried P.A., Watkinson B., Gray R. Neurocognitive consequences of marihuana-a comparison with pre-drug performance. Neurotoxicology and Teratology 2005, 27:231-239.
15. Gouzoulis-Mayfrank E., Voss T., Mörth D., Thelen B., Spitzer M., Meincke U. Semantic hyperpriming in thought-disordered patients with schizophrenia: state or trait?-a longitudinal investigation. Schizophrenia Research 2003, 65(3):65-73.
16. Kischka U., Kammer T., Maier S., Weisbrod M., Thimm M., Spitzer M. Dopaminergic modulation of semantic network activation. Neuropsychologia 1996, 34:1107-1113.
17. Lupica C.R., Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005, 48:1105-1116.
18. Manschreck T.C., Maher B.A., Milavetz J.J., Ames D., Weisstein C.C., Schneyer M.L. Semantic priming in thought disordered schizophrenic patients. Schizophrenia Research 1988, 1:61-66.
19. Mason O.J., Morgan C.J., Stefanovic A., Curran H.V. The Psychotomimetic States Inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research 2008, 103:138-142.
20. Messinis L., Kyprianidou A., Malefaki S., Papathanasopoulos P. Neuropsychological deficits in long-term frequent cannabis users. Neurology 14-3-2006, 66:737-739.
21. Meyer D., Schvanevedlt R. Facilitation in recognizing pairs of words: evidence of a dependence on retrieval operations. Journal of Experimental Psychology 1971, 90:227-234.
22. Minzenberg M.J., Ober B.A., Vinogradov S. Semantic priming in schizophrenia: a review and synthesis. Journal of the International Neuropsychological Society 2002, 8:699-720.
23. Morgan C.J.A., Bedford N., Rossell S.L. Evidence of semantic disorganisation using semantic priming in individuals with high schizotypy. Schizophrenia Research 2006, 24-3-2006a.
24. Morgan C.J.A., Rossell S.L., Pepper F., Smart J., Blackburn J., Brandner B., Curran H.V. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry 2006, 59:265-272. 1-2-2006b.
25. Moritz S., Mersmann K., Kloss M., Jacobsen D., Wilke U., Andersen B., Naber D., Pawlik K. 'Hyper-priming' in thought disordered schizophrenic patients. Psychological Medicine 2001, 31:221-229.
26. Moritz S., Woodward T.S., Kuppers D., Lausen A., Schickel M. Increased automatic spreading of activation in thought-disordered schizophrenic patients. Schizophrenia Research 2003, 59(2-3):181-186. 2003 Feb 1.
27. Neely J.H., Keefe D.E. Semantic context effects on visual word processing: a hybrid prospective/retrospective processing theory. The Psychology of Learning and Motivation: Advances in Research and Theory 1989, 207-248. Academic Press, New York. G.H. Bower (Ed.).
28. Nunn J.A., Rizza F., Peters E.R. The incidence of schizotypy among cannabis and alcohol users. Journal of Nervous and Mental Disease 2001, 189:741-748.
29. Pope H.G., Gruber A.J., Hudson J.I., Huestis M.A., Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry 2001, 58:909-915.
30. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 1991, 17:555-564.
31. Ranganathan M., D'Souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) 2006, 188:425-444.
32. Rastle K., Harrington J., Coltheart M. 358 534 non words: The ARC non-word database, Quarterly. Journal of Experimental Psychology 2002, Section A(55):1339-1362.
33. Schiffman J., Nakamura B., Earleywine M., LaBrie J. Symptoms of schizotypy precede cannabis use. Psychiatry Research 30-3-2005, 134:37-42.
34. Shelton J.R., Martin R.C. How semantic is automatic semantic priming?. Journal of Experimental Psychology. Learning, Memory, and Cognition 1992, 18:1191-1210.
35. Skosnik P.D., Spatz-Glenn L., Park S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 1-3-2001, 48:83-92.
36. Solowij N., Hall W., Lee N. Recreational MDMA use in Sydney: a profile of "Ecstasy" users and their experience with the drug. British Journal of Addiction 1992, 87:1161-1172.
37. Spitzer M., Braun U., Hermle L., Maier S. Associative semantic network dysfunction in thought disordered schizophrenic patients: direct evidence for indirect semantic priming. Biological Psychiatry 1993, 34:864-877.
38. Spitzer M., Thimm M., Hermle L., Holzmann P., Kovar K.A., Heimann H., Gouzoulis-Mayfrank E., Kischka U., Schneider F. Increased activation of indirect semantic associations under psilocybin. Biological Psychiatry 1996, 39:1055-1057.
39. Verdejo-Garcia A.J., Lopez-Torrecillas F., Aguilar d.A., Perez-Garcia M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addictive Behaviors 2005, 30:89-101.
40. Wadsworth E.J., Moss S.C., Simpson S.A., Smith A.P. Cannabis use, cognitive performance and mood in a sample of workers. Journal of Psychopharmacology 2006, 20:14-23.
41. Williams J.H., Wellman N.A., Rawlins J.N. Cannabis use correlates with schizotypy in healthy people. Addiction 1996, 91:869-877.
42. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983, 67:361-370.